Category: Stocks
Attention biotech investors: Monday agenda for this week’s JP Morgan healthcare conference
More info on the conference here.
Earnings growth to step back in 2019 but no one should be surprised
Source: Refinitiv
The above is an excerpt from Refinitiv’s weekly earnings report.
The bit that investors need to keep an eye on is the earnings growth rate for the next four quarters.
The next set of earnings reports should show S&P 500 companies grew earnings per share 15.1% in Q4 2018 (look for the number to end up higher as the real numbers come through).
But you can see the Q1, Q2 and Q3 numbers for 2019 are expected to fall back into the single digits, partly a function of earnings cycling the corporate tax cuts last year, as mentioned here previously.
Some strategists estimated the tax cuts added around eight percentage points to 2018 earnings growth so it shouldn’t be a surprise that growth is harder to come by this year. But that has nothing to do with the companies doing it tougher or the economy going into recession. That, folks, is just math.
What happens on Monday…in the IPO market?
Not much. A few people have been asking me what impact the government shutdown has on the US IPO market and ECM activity generally as it restarts in 2019.
The basic answer is that no IPO is able to price until the shutdown is over, though with financial markets so choppy, it is kind of a moot point anyway.
Since late last month, the Securities and Exchange Commission has been operating with a skeleton staff. The corporate watchdog has already told issuers and their advisers it won’t be able to declare their registration statements “effective”.
This includes the S-1 statements that IPO aspirants have to file before they can raise cash from investors.
What does that mean? Effectiveness is one of the final steps before a company goes public under US securities regulations, which require new securities to be registered with the SEC.
So without the ability to get effective, companies can’t go public.
Of course, an issuer could launch an IPO in the hope that by the time its investor roadshow ends (usually seven or eight business days) the shutdown will be over. And there’s been some talk about ways to sidestep the SEC, but they are not practical, at least for mainstream IPOs.
The talk among bankers is that, notwithstanding Friday’s impressive up move in stocks, no one really wants to go first here until market conditions stabilize properly.
You never know, maybe that happens now that the Fed and the market are on the same page (maybe?).
Based on recent filings and taking into account deals that were delayed in the final months of 2018, there were maybe 10 or more companies that would have tried to go in January absent the shutdown.
A lot of these would have been biotechs and China-to-US deals that have big insider backing, de-risking their fundraising and making somewhat insensitive to market conditions.
Hard to say when this shutdown ends (no progress today) but until then the IPO market is on ice.
As for follow-ons, well-known seasoned issuers and companies with existing shelf registrations can price stock offerings, but it doesn’t sound like it will be a flood.
That said, with Friday’s surge maybe some investors that have managed to put 2018 behind them and are now sniffing better times ahead will be prepared to put new money to work.
US ECM activity in 2018: Deutsche Bank
These numbers are from Deutsche Bank, but here’s a few points I would add:
1) Activity increased across all ECM formats, except blocks. Blocks – often secondary sponsor selldowns – traded poorly and private equity firms also completed the monetization of many of their public holdings (Sabre, Norwegian Cruise Line and Hilton Worldwide are three that come to mind).
2) Though tech and healthcare dominated deal activity, the sector that really saw a big jump in deal flow was utilities. Somewhat counter-intuitively, corporate tax reform crimping the balance sheets/credit ratings of regulated utility owners, requiring them to raise equity, drove much of this activity.
3) The IPO backlog is pretty light at this point and may stay that way at the start of 2019 (not least because of the government shutdown), though it should really fire up in March/April when Uber/Lyft come to market.
4) REITs, energy and industrials were three sectors that saw issuance fall in 2018. Leveraged IPOs, often industrial companies, fell out of favor following the ADT disaster in January.
AMD, Abiomed, Fortinet led S&P 500 constituents in brutal 2018
Merck, Pfizer led DJIA in tough 2018, Goldman, IBM lag
DJIA constituent returns (column 4 for 2018 full year returns)
Source: Refinitiv/Eikon